Micronisation of carbamazepine through rapid expansion of supercritical solution (RESS)

Journal of Supercritical Fluids

Volumn 62, Issue , 2012, Pages 32-40

  Bolten, Dennis ^a   Türk, Michael ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Carbamazepine; Dissolution behavior; Polymorphism; RESS; Supercritical CO 2

Indexed keywords

CARBAMAZEPINE; DISSOLUTION BEHAVIOR; DISSOLUTION RATES; HUMAN BODIES; MICRONISATION; NANO-EMULSIONS; PHARMACEUTICAL COMPOUNDS; POLYMERIC MICELLE; POLYMORPHIC FORMS; POORLY WATER-SOLUBLE DRUGS; RAPID EXPANSION OF SUPERCRITICAL SOLUTIONS; RESS; SIDE EFFECT; SUBMICRON; SUPERCRITICAL CO; WATER SOLUBILITIES;

CARBON DIOXIDE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DOSAGE; DRUG INTERACTIONS; ELECTROMAGNETIC WAVE EMISSION; EMULSIONS; EXPANSION; POLYMORPHISM; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

AMIDES;

EID: 84855828555     PISSN: 08968446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.supflu.2011.06.014     Document Type: Article

References (55)

1. R. Hilfiker, M. von Raumer, A. Geoffroy, F. Blatter, and H.-W. Haesslin Bioperformance improvement: small particles and optimal polymorphs Chimia 55 2001 699 703
2. R. Hilfiker, F. Blatter, and M. von Raumer Relevance of solid-state properties for pharmaceutical products R. Hilfiker, Polymorphism in the pharmaceutical industry 2006 Wiley-VCH Weinheim 1 20
3. J. Haleblian, and W. McCrone Review: pharmaceutical applications of polymorphism Journal of Pharmaceutical Sciences 58 1969 911 929
4. D. Singhal, and W. Curatolo Drug polymorphism and dosage form design: a practical perspective Advanced Drug Delivery Reviews 56 2004 335 347 (Pubitemid 38201429)
5. E. Mutschler, G. Geisslinger, H.K. Kroemer, P. Ruth, and M. Schäfer-Korting 9th ed. Mutschler Arzneimittelwirkungen - Lehrbuch der Pharmakologie und Toxikologie 2008 Wissenschaftliche Verlagsgesellschaft Stuttgart pp. 312-315
6. J.M. Pellock, B.F.D. Bourgeois, W.E. Dodson, D.R. Nordli Jr., and R. Sankar 3rd ed. Pediatric Epilepsy: Diagnosis and Therapy 2008 Demos New York pp. 567-578
7. M.E. Brewster, W.R. Anderson, K.S. Estes, and N. Bodor Development of aqueous paren-teral formulations for carbamazepine through the use of modified cyclodextrins Journal of Pharmaceutical Sciences 80 1991 380 383
8. T. Takagi, C. Ramachandran, M. Bermejo, S. Yamashita, L.X. Yu, and G.L. Amidon A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan Molecular Pharmaceutics 3 2006 631 643 (Pubitemid 46087480)
9. W.I Wilson, Y. Peng, and L.L. Augsburger Comparison of statistical analysis and bayesian networks in the evaluation of dissolution performance of BCS class II model drugs Journal of Pharmaceutical Sciences 94 2005 2764 2776 (Pubitemid 43265398)
10. P.M. Gosselin, R. Thibert, M. Preda, and J.N. McMullen Polymorphic properties of micronized carbamazepine produced by RESS International Journal of Pharmaceutics 252 2003 225 233 (Pubitemid 36126631)
11. A.L. Grzesiak, M. Lang, K. Kim, and A.J. Matzger Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I Journal of Pharmaceutical Sciences 92 2003 2260 2271 (Pubitemid 37356699)
12. R. Ceolin, S. Toscani, M.-F. Gardette, V.N. Agafonov, A.V. Dzyabchenko, and B. Bachet X-ray characterisation of the triclinic polymorph of carbamazepine Journal of Pharmaceutical Sciences 86 1997 1062 1065
13. M. Lang, J.W. Kampf, and A.J. Matzger Form IV of carbamazepine Journal of Pharmaceutical Sciences 91 2002 1186 1190 (Pubitemid 34640943)
14. S.R. Carino, D.C. Sperry, and M. Hawley Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model Journal of Pharmaceutical Sciences 95 2006 116 125
15. M.M.J. Lowes, M.R. Caira, A.P. Lötter, and J.G. Van der Watt Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine Journal of Pharmaceutical Sciences 76 1987 744 752 (Pubitemid 18026986)
16. S.-D. Yeo, and E. Kiran Formation of polymer particles with supercritical fluids: a review Journal of Supercritical Fluids 34 2005 287 308 (Pubitemid 40584247)
17. M. Perrut, J. Jung, and F. Leboeuf Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes part I: micronization of neat particles International Journal of Pharmaceutics 288 2005 3 10 (Pubitemid 39656449)
18. E. Reverchon, and R. Adami Review: nanomaterials and supercritical fluids Journal of Supercritical Fluids 37 2006 1 22
19. M. Bahrami, and S. Ranjbarian Production of micro- and nano-composite particles by supercritical carbon dioxide Journal of Supercritical Fluids 40 2007 263 283 (Pubitemid 46172528)
20. A. Tandya, R. Mammucari, F. Dehghani, and N.R. Foster Dense gas processing of polymeric controlled release formulations International Journal of Pharmaceutics 328 2007 1 11 (Pubitemid 44827561)
21. K. Mishima Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas Advanced Drug Delivery Reviews 60 2008 411 432 (Pubitemid 351222677)
22. A. Martin, and M.J. Cocero Micronization processes with supercritical fluids: fundamentals and mechanisms Advanced Drug Delivery Reviews 60 2008 339 350 (Pubitemid 351215568)
23. E. Stahl, K.-W. Quirin, and D. Gerard Verdichtete Gase zur Extraktion und Raffination 1987 Springer Berlin pp. 10-36
24. Y. Yamini, J. Hassan, and S. Haghgo Solubilities of some nitrogen-containing drugs in supercritical carbon dioxide Journal of Chemical and Engineering Data 46 2001 451 455 (Pubitemid 32380433)
25. A.D. Edwards, B.Y. Shekunov, A. Kordikowski, R.T. Forbes, and P. York Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS™) Journal of Pharmaceutical Sciences 90 2001 1115 1124
26. R. Bettini, L. Bonassi, V. Castoro, A. Rossi, L. Zema, A. Gazzaniga, and F. Giordano Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide European Journal of Pharmaceutical Sciences 13 2001 281 286 (Pubitemid 32522580)
27. 2: solubility, solid state and chemical modifications Journal of Thermal Analysis and Calorimetry 77 2004 625 638
28. 2 on crystalline to amorphous conversion of carbamazepine International Journal of Pharmaceutics 333 2007 152 161 (Pubitemid 46283281)
29. S. Sethia, and E. Squillante Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods International Journal of Pharmaceutics 272 2004 1 10 (Pubitemid 38293005)
30. M. Moneghini, I. Kikic, D. Voinovich, B. Perissutti, and J. Filipović-Grčić Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution International Journal of Pharmaceutics 222 2001 129 138 (Pubitemid 32525794)
31. M. Moneghini, I. Kikic, D. Voinovich, B. Perissutti, P. Alessi, A. Cortesi, F. Princivalle, and D. Solinas Study of the solid state of carbamazepine after processing with gas anti-solvent technique European Journal of Pharmaceutics and Biopharmaceutics 56 2003 281 289 (Pubitemid 37072113)
32. M. Türk Manufacture of submicron drug particles with enhanced dissolution behaviour by rapid expansion processes Journal of Supercritical Fluids 47 2009 537 545
33. M. Türk, and D. Bolten Formation of submicron poorly water-soluble drugs by rapid expansion of supercritical solution (RESS): results for naproxen Journal of Supercritical Fluids 55 2010 778 785
34. P. Gosselin, F.-X. Lacasse, M. Preda, R. Thibert, S.-D. Clas, and J.N. McMullen Physicochemical evaluation of carbamazepine microparticles produced by the rapid expansion of supercritical solutions and by spray-drying Pharmaceutical Development and Technology 8 2003 11 20 (Pubitemid 36337474)
35. Deutsches Arzneibuch Methoden zur Pharmazeutischen Technologie 1996 Deutscher Apotheker Verlag Stuttgart
36. The United States Pharmacopeia (USP 32) 2009 United States Pharmacopeial Convention Inc. Rockville, MD
37. 2 Journal of Chemical and Engineering Data 54 2009 1592 1597
38. M. Türk, and R. Signorell In situ characterization of drug nanoparticles by FTIR-spectroscopy C.S.S.R. Kumar, Nanotechnologies for the Life Sciences, Vol. 3. Nanosystem Characterization Tools in the Life Sciences 2005 Wiley-VCH Weinheim 208 240
39. M. Türk, G. Upper, and P. Hils Formation of composite drug-polymer particles by co-precipitation during the rapid expansion of supercritical fluids Journal of Supercritical Fluids 39 2006 253 263 (Pubitemid 44636148)
40. CCDC, The Cambridge Crystallographic Data Centre, Cambridge, UK, 2009, www.ccdc.cam.ac.uk.
41. K. Eichhorn, Laboratorium für Applikationen der Synchrotronstrahlung (LAS), Karlsruhe Institute of Technology (KIT), Private Communication, 2010.
42. P.J.P. Reboul, B. Cristau, J.C. Soyfer, and J.P. Astier 5H-dibenz[b,f]acepinecarboxamide-5 (carbamazepine) Acta Crystallographica B37 1981 1844 1848
43. V.L. Himes, A.D. Mighell, and W.H. De Camp Structure of carbamazepine: 5H-dibenz[b,f]azepine-5-carboxamide Acta Crystallographica B37 1981 2242 2245
44. N. Kaneniwa, T. Yamaguchi, N. Watari, and M. Otsuka Hygroscopy of carbamazepine crystalline powders Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan 104 1984 184 190
45. C. McGregor, M.H. Saunders, G. Buckton, and R.D. Saklatvala The use of high-speed differential scanning calorimetry (Hyper-DSC™) to study the thermal properties of carbamazepine polymorphs Thermochimica Acta 417 2004 231 237
46. F.U. Krahn, and J.B. Mielck Relations between several polymorphic forms and the dihydrate of carbamazepine Pharmaceutica Acta Helvetiae 62 1987 247 254 (Pubitemid 18073853)
47. S.A. Mitchell, T.D. Reynolds, and T.P. Dasbach A comparison process to enhance dissolution of poorly water-soluble drugs using hydroxypropylmethylcellulose International Journal of Pharmaceutics 250 2003 3 11 (Pubitemid 35447932)
48. H. Lee, S.-A. Park, and H. Sah Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet Archives of Pharmacal Research 28 2005 120 126 (Pubitemid 44698777)
49. K. Tsinman, A. Avdeef, O. Tsinman, and D. Voloboy Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility drugs Pharmaceutical Research 26 2009 2093 2100
50. S. Müller, diploma thesis, Karlsruhe Institute of Technology (KIT), 2010.
51. P.W. Atkins Physikalische Chemie 1st ed. 1987 VCH, Weinheim pp. 710-711, translated by A. Höpfner
52. A.W. Hixson, and J.H. Crowell Dependence of reaction velocity upon surface and agitation: I-theoretical considerations Industrial and Engineering Chemistry 23 1931 923 931
53. M. Charoenchaitrakool, F. Dehghani, N.R. Foster, and H.K. Chan Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals Industrial and Engineering Chemical Research 39 2000 4794 4802
54. M. Türk, P. Hils, B. Helfgen, K. Schaber, H.-J. Martin, and M.A. Wahl Micronization of pharmaceutical substances by rapid expansion of supercritical solutions (RESS): a promising method to improve the bioavailability of poorly soluble pharmaceutical agents Journal of Supercritical Fluids 22 1 2002 75 84
55. M. Türk, and R. Lietzow Formation and stabilization of submicron particles via rapid expansion processes Journal of Supercritical Fluids 45 2008 346 355